Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
EGR2
is a human zinc finger encoding gene whose expression is induced with fos-like kinetics by diverse mitogens in several cell types. Since its cDNA sequence predicts a protein which contains zinc finger motifs,
EGR2
may play a transcriptional regulatory role in cellular proliferation. The present study was undertaken to: 1) examine the genomic organization and 5' flanking sequence of
EGR2
so as to identify upstream regulatory elements; 2) test whether these elements are functional in gel shift assays and by transient expression; and 3) examine whether pathways other than protein kinase C lead to serum induction of
EGR2
, and if they do, ask whether the different pathways converge on a serum response element. The
EGR2
gene spans 4.3 kb and has one intron. The translation initiation site is located within the first exon. The transcription start site of
EGR2
was determined by
S1 nuclease
and primer extension analysis and a TATA box was identified 28 bp upstream. Two putative serum response elements, designated CArG-1 and CArG-2 were identified in the 5' flanking sequence. By deletion analyses and mutagenesis, serum and PMA responsiveness of the cloned
EGR2
promoter region was traced to the CArG-1 region in transient CAT assays performed in NIH 3T3 cells. Both protein kinase C dependent and independent pathways were found to converge on the CArG-1 box to induce the expression of
EGR2
.
...
PMID:The serum and TPA responsive promoter and intron-exon structure of EGR2, a human early growth response gene encoding a zinc finger protein. 211 Oct 9